Zoonotic multidrug-resistant microorganisms among non-hospitalized horses from Germany by Kaspar, Ursula et al.
Contents lists available at ScienceDirect
One Health
journal homepage: www.elsevier.com/locate/onehlt
Zoonotic multidrug-resistant microorganisms among non-hospitalized
horses from Germany
Ursula Kaspara,1, Knut von Lützaua, Andreas Schlattmanna, Uwe Röslerb, Robin Köcka,2,
Karsten Beckera,⁎
a Institute of Medical Microbiology, University Hospital Münster, Münster, Germany
b Institute for Animal Hygiene and Environmental Health, FU Berlin, Department of Veterinary Medicine, Berlin, Germany















A B S T R A C T
Colonization with multidrug-resistant organisms (MDROs) belonging to the genus Staphylococcus and the order
Enterobacterales poses a particular threat to populations at risk. While previous studies focused on MDRO car-
riage among livestock or companion animals, respective epidemiological data on the general equine population
are limited. Here, carriage of methicillin-resistant Staphylococcus aureus (MRSA) and extended spectrum beta-
lactamase (ESBL) producing Enterobacteriaceae (ESBL-E) in non-hospitalized horses living on private farms in the
rural area in Northwest Germany was assessed. Intranasal and perianal swab samples were cultured on solid
chromogenic media directly and after enrichment in tryptic soy broth, respectively. S. aureus isolates were spa-
typed, MRSA and ESBL-E were further classiﬁed by phenotypic and molecular methods. Additionally, a subgroup
of the ﬁrst 20 samples was used to isolate and characterize staphylococci other than S. aureus. Among 223
horses, ﬁfteen (6.8%) carried S. aureus. Two isolates were identiﬁed as MRSA (0.9% of all horses, mecA-positive)
and classiﬁed as spa types t011 and t6867, both known as members of the livestock-associated MRSA MLST
clonal complex 398. Nine horses (4.0%) were colonized by ESBL-Escherichia coli positive for blaCTX-M and/or
blaTEM. ESBL-E carriage was associated with prior antibiotic treatment (4/31 vs. 5/183; p=0.0362) and ve-
terinary examinations (4/31 vs. 5/183; p= 0.0362). In the subgroup, nine diﬀerent staphylococcal species other
than S. aureus were found. The high prevalence of ESBL-E. coli in non-hospitalized horses underlines the ne-
cessity to raise awareness for strain dissemination across diﬀerent hosts in order to do justice to the “One Health”
concept.
1. Introduction
Horses may carry opportunistic pathogens including multidrug-re-
sistant organisms (MDROs), which can also be transmitted between
horses and other host species including humans [1–3]. Of high interest
are methicillin-resistant staphylococci (MRS), in particular Staphylo-
coccus aureus (MRSA) and species of the Staphylococcus intermedius
group (SIG), or extended spectrum beta-lactamase (ESBL) producing
Enterobacteriaceae (ESBL-E). Co-colonization of antibiotic-resistant with
non-resistant bacteria may facilitate the exchange of resistance genes
contributing to the global antibiotic resistance threat [4,5]. Particularly
genes of the mec-family (mecA-D) in Staphylococcus and Macrococcus
species and of the bla-family (blaSHV, blaTEM, blaCTX-M, blaCMY-2) in
species of the order Enterobacterales, encoding ESBLs, are of major
interest [6–10].
In this study, we assessed the prevalence of MRSA, other MRS and
ESBL-E among non-hospitalized horses in a rural area in Northwest
Germany and characterized the respective isolates using phenotypic as
well as molecular methods.
2. Materials and methods
2.1. Sample collection
Between May 2015 and March 2016, samples were collected from
23 farms of 223 non-hospitalized horses living on private farms in the
rural area around the city of Münster, North Rhine-Westphalia,
Germany. Of these, samples came from 38 animals living with ≤10
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horses, 57 with 11–30 horses, and 128 with ≥30 horses on the same
farm. Swab samples (Transwab Amies MW 172P, Medical Wire &
Equipment, Corsham Wiltshire, England) were collected from each
animal's nasal vestibules (both sides with one swab) and perianal area.
Samples were always taken by a trained veterinarian with full consent
of horse owners and a questionnaire was ﬁlled out for every horse. Data
obtained regarded sex, age, reason for veterinary examination where
applicable, antibiotic treatment within the last six months, stay in a
veterinary clinic, and contact with livestock. Samples were stored at
room temperature for a maximum of two days before being further
processed.
2.2. Cultivation
Nasal swabs were streaked onto a selective chromogenic medium
(chromID® S. aureus, bioMérieux, Marcy l'Étoile, France), then sus-
pended in 5ml of tryptic soy broth (TSB, Becton Dickinson, Franklin
Lakes, NJ, USA) supplemented with 6.5% NaCl. Solid and liquid cul-
tures were incubated at 37 °C for 24 h. From enriched liquid cultures,
10 μl were inoculated on (i) chromID® S. aureus medium (bioMérieux),
and (ii) chromogenic medium selective for MRSA (chromID® MRSA,
bioMérieux). Another 1ml was transferred into an MRSA enrichment
broth, i.e. phenol red mannitol broth supplemented with ceftizoxim/
aztreonam (9ml, PHMB+C/AZ, Mediaproducts BV, Groningen, The
Netherlands). Cultures were further incubated at 37 °C for 24 h
(chromID® S. aureus and PHMB+C/AZ) or 48 h (chromID® MRSA),
respectively. From the PHMB+C/AZ culture, 1 ml was given onto
chromID® MRSA (bioMérieux) and further incubated at 37 °C for 48 h.
Moreover, nasal swabs sampled from the ﬁrst 20 horses were ad-
ditionally streaked onto Columbia CAP selective agar (containing co-
listin and aztreonam) with 5% sheep blood (Oxoid, Wesel, Germany)
and incubated at 37 °C for 24 h in order to isolate and characterize
staphylococci other than S. aureus.
Perianal swab samples were suspended in TSB and incubated at
37 °C for 24 h. The enriched culture (10 μl) was inoculated on a chro-
mogenic selective medium (chromID® ESBL, bioMérieux) and further
incubated at 37 °C for 24 h.
2.3. Identiﬁcation of isolates
Colonies grown on solid media were tentatively isolated based on
conventional phenotypic characteristics, such as colony morphology,
pigmentation, Gram staining and production of clumping factor
(Pastorex Staph Plus; bioMérieux). Further incubation of pure cultures
was carried out on Columbia blood agar (Becton Dickinson) at 37 °C for
24 h.
Isolates were identiﬁed down to the species level applying matrix-
assisted laser desorption/ionization-time-of-ﬂight mass spectrometry
(MALDI-TOF MS, Bruker Daltonics, Billerica, MA) as described else-
where [11]. Brieﬂy, material from freshly grown single colonies was
transferred onto a ground steel target plate (Bruker Daltonics) and
covered with 1 μl of alpha-cyano-4-hydroxycinnamic acid (HCCA) dis-
solved in 50.0% acetonitrile and 2.5% triﬂuoroacetic acid. Co-crystal-
lized samples were analyzed in ﬂexControl 3.3 (Bruker Daltonics).
Evaluation via MALDI Biotyper® 4.0 (Bruker Daltonics) was set to an m/
z range of 4000–10,000 Da and a score threshold ≥2.0 for un-
ambiguous assignment on species level.
Bacterial isolates yielding scores ≤2.0 in MALDI-TOF MS analysis
were further intended for biochemical identiﬁcation in the VITEK® 2
automated system (bioMérieux) applying VITEK® 2 GP ID cards for
nasal and VITEK® 2 GN ID cards (bioMérieux) for perianal samples,
respectively.
For isolates with ambiguous identiﬁcation results by both MALDI-
TOF MS and VITEK® 2, 16S rRNA gene sequencing was performed.
Extraction of total genomic DNA was performed with the QIAamp DNA
MiniKit according to the manufacturer's instructions (Qiagen, Venlo,
Netherlands). V1-V4 hypervariable regions of the 16S rRNA gene were
ampliﬁed using primers 27f and 907r(m) [12,13]. PCR products were
puriﬁed with the MinElute Kit (Qiagen) following the manufacturer's
instructions. The cycle sequencing technology on an ABI 3730XL se-
quencing machine was used (Euroﬁns Genomics, Ebersberg, Germany).
Sequences obtained were compared against data from validly described
type strains of the RDP-II database [14]. The threshold for assignment
on species level was set to ≥98% similarity.
2.4. Characterization of isolates
Phenotypic antimicrobial susceptibility was tested for all isolates
using the VITEK® 2 system (bioMérieux) according to the manufac-
turer's instructions with test cards AST-P632 for staphylococci and AST-
N214 for Enterobacteriaceae. Evaluation of AST test results was carried
out according to the clinical breakpoints for humans of the European
Committee on Antimicrobial Susceptibility Testing (EUCAST) [15].
In staphylococci, presence of the genes mecA, mecB and mecC con-
ferring methicillin resistance was tested by PCR as introduced else-
where [6,16]. Genotyping of S. aureus isolates was done by spa typing;
MRSA were additionally classiﬁed by multilocus sequence typing
(MLST) as previously described [17,18].
For Enterobacteriaceae, ESBL-production indicated by VITEK was
conﬁrmed using the MASTDISCS™ ID Extended-Spektrum-β-
Laktamasen (ESβL)-Set (CPD10) D67C (MAST Diagnostica, Reinfeld,
Germany). Genetic basis of antibiotic resistance was determined by
PCR-based analysis of the genes blaSHV, blaTEM, blaCTX-M and blaCMY-2
[19,20] and applying the eazyplex® SuperBug assay (AmplexDiagnos-
tics GmbH, Gars am Inn, Germany) for detection of carbapenemase-
producing Enterobacteriaceae (CRE).
Fisher's exact test (GraphPad Prism v.5.00, GraphPad Software, La
Jolla, CA, USA) was carried out to analyze association of ESBL-E and
MRSA carriage with potential risk factors. The probability value of




Altogether, nasal and perianal samples from 223 horses originating
from 23 diﬀerent farms located in six diﬀerent rural districts around
Münster, North Rhine-Westphalia were included in this study. The
group comprised 94 mares, 25 stallions and 104 geldings with a mean
age of 9.2 years (range 0–31 years). The majority of horses was healthy
(188/223; 84.3%) whereas 35/223 animals (15.7%) were sampled
before undergoing veterinary examination. Moreover, 34/223 horses
(15.2%) had received systemic antibiotics and 31/223 horses (13.9%)
had been admitted stationary to a veterinary clinic within six months
prior to sampling. Of all horses, 158 (70.9%) were held without close
contact to livestock, i.e. no livestock was being kept on the farm with
the horses. The remaining horses were held with pigs (32/223; 14.3%),
cattle (8/223; 3.6%) and poultry (25/223; 11.2%) on the same farm.
Further information is given in Table 1.
3.2. Colonization with ESBL-E
Colonization with ESBL-E was detected in the perianal samples from
9/223 horses (4.0%) living on 7/23 farms (30.4%). Four of these farms
held 11–30 horses, 3 farms ≥30 horses. All isolates were found to
belong to the species Escherichia coli. Overall, 3/94 mares (3.2%), 1/25
stallions (4.0%) and 5/104 geldings (4.8%) were colonized. Their mean
age was 12.4 years (range 4–31 years) and 4/9 animals were introduced
to a veterinarian, either for internal diseases (2/4), orthopedics (1/4) or
surgical interventions (1/4). Moreover, 4/9 horses had received anti-
biotics within six months prior to sampling. One gelding was kept
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together with pigs, cattle and poultry, one mare together with poultry
and another mare together with pigs.
All E. coli isolates were susceptible to ertapenem, imipenem, mer-
openem, tigecycline and piperacillin/tazobactam. Molecular tests con-
ﬁrmed presence of the genes blaTEM and blaCTX-M in 7/9 ESBL-E ex-
hibiting either a single gene type (blaCTX-M: n= 2) or a compound-gene
type (blaTEM and blaCTX-M: n= 5) (Table 2). Neither blaTEM nor blaCTX-M
were detected in the remaining two isolates phenotypically conﬁrmed
as ESBL-E.
3.3. Colonization with S. aureus
In the group of 223 horses, 15 horses (6.7%) living on 10/23 farms
(43.5%) carried S. aureus in the nose. One of these farms held ≤10
horses, three held 11–30 horses, and six held ≥30 horses. One isolate
was picked directly from SAID medium, fourteen were isolated after
enrichment. Among the colonized horses, there were six mares (6/94;
6.4%), two stallions (2/25; 8.0%) and seven geldings (7/104; 6.7%).
The mean age of this group was 12.1 years (range 5–25 years) and 3/15
animals had been admitted to a veterinary clinic because of internal (1/
3) or orthopedic (1/3) diseases or complicated foaling (1/3). Four of the
S. aureus-carrying horses (4/15; 26.7%) had received antibiotics within
a time period of six months before samples were taken. Moreover, 2/15
horses (13.3%) were kept in close contact to livestock: one mare was
held together with pigs and one stallion was held together with pigs and
cattle. Only one nasal S. aureus strain was detected per horse.
S. aureus strains (n= 15) were assigned to spa types t091 (n=3),
t127, t549, t1166, t3218 (each n=2), t011, t233, t768 and t6867
(each n= 1). Methicillin resistance was found in 2/15 isolates (2/223
horses; 0.9%) and was always conﬁrmed by the detection of the mecA
gene. Isolates belonged to spa types t011 and t6867, known as part of
the livestock-associated (LA) MRSA clonal complex (CC) 398. Both LA-
MRSA isolates showed further resistance against gentamicin, tetra-
cycline and trimethoprim-sulfamethoxazole when tested with the
VITEK® 2 system (Table 3). MRSA t011 was additionally resistant
against clindamycin and erythromycin. Both LA-MRSA-carrying ani-
mals were healthy mares not undergoing veterinary examination. They
were ﬁve and ten years of age and had not received any antibiotics in
the time before sampling. One of the mares, colonized with MRSA t011,
was kept together with pigs.
3.4. Association of risk factors with ESBL-E and MRSA carriage
Regarding the equine colonization with ESBL-E. coli, antibiotic
treatment (4/31 vs. 5/183; p= 0.0362) and veterinary examinations
(4/31 vs. 5/183; p= 0.0362) were identiﬁed as risk factors. Coinciding
numbers of animals treated with antibiotic substances and those un-
dergoing veterinary examination were not based on identical compo-
sition of the groups. None of the other risk factors assessed was asso-
ciated with ESBL-E. coli or MRSA carriage (p > 0.05 for all variables).
3.5. Colonization with other staphylococci
The subgroup of horses (n= 20) analyzed for staphylococcal species
other than S. aureus, consisted of six mares, three stallions and eleven
geldings. A total of nine diﬀerent staphylococcal species other than S.
aureus including one coagulase-positive and eight coagulase-negative
members could be detected in this group (Fig. 1).
The most prevalent species was Staphylococcus xylosus (14/20 ani-
mals; 70%), followed by Staphylococcus vitulinus (10/20 animals; 50%),
Staphylococcus sciuri (8/20 animals; 40%) and Staphylococcus succinus
(6/20 animals; 30%). Staphylococcus haemolyticus and Staphylococcus
lentus were only found in stallions (each in 1/3), whereas Staphylococcus
equorum and the coagulase-positive species Staphylococcus delphini
(member of the S. intermedius group) were only present in geldings
Table 1
Metadata of horses sampled.
Factor Mare Stallion Gelding Total
Age (y)
- Mean 9.8 6.9 9.1 9.2
- Range 0–31 0–18 3–30 0–31
Reason for veterinary examination
- Complicated foaling 1 0 0 1
- Dental treatment 0 0 2 2
- Internal diseasea 3 2 3 8
- Surgical interventionb 8 0 5 13
- Orthopedic diseasec 4 2 5 11
Antibioticsd
- Systemic 14 4 16 34
- No antibiotics 80 21 88 189
Stay in veterinary clinicd
- Yes 15 4 12 31
- No 79 21 92 192
Contact with livestock
- Pigs 11 6 15 32
- Cattle 3 2 3 8
- Poultry 14 1 10 25
Total 94 25 104 223
a Internal disease; disease of digestive tract, urogenital tract, circulatory
system, nervous system, skin, eyes, ears, or metabolism;
b Surgical intervention; sterilization, wound management, orthopedic sur-
gery, or tumor resection;
c Orthopedic disease; diagnosis of lameness, radiography, or bandage man-
agement;
d Within six months prior to sampling.
Table 2
Resistance proﬁles of ESBL-E. coli found in 223 horses.
Animal host Sampling site Resistance genes Phenotypic antimicrobial susceptibility test proﬁle
ESBLa-screening Other resistancesb
Gelding Perianal blaCTX-M, blaTEM POS AMP, AMS, CPO, CTA, CUR, TRS
Gelding Perianal blaCTX-M POS AMP, CTZ, CIP, CPO, CTA, CUR, GEN, MOX, TRS
Gelding Perianal blaCTX-M, blaTEM POS AMP, AMS, CPO, CTA, CUR, GEN, TRS
Stallion Perianal blaCTX-M, blaTEM POS AMP, AMS, CPO, CTA, CUR, GEN, TRS
Gelding Perianal blaCTX-M POS AMP, CPO, CTA, CUR, GEN, TRS
Gelding Perianal blaCTX-M, blaTEM POS AMP, AMS, CPO, CTA, CUR, GEN, MOX, TRS
Mare Perianal n.a. POS AMP, CIP, CPO, CTA, CTZ, CUR, MOX, TRS
Mare Perianal n.a. POS AMP, CPO, CTZ, MOX, TRS
Mare Perianal blaCTX-M, blaTEM POS AMP, AMS, CPO, CTA, CUR, GEN, TRS
AMP, ampicillin; AMS, ampicillin-sulbactam; CIP, ciproﬂoxacin; CPO, cefpodoxime; CTA, cefotaxime; CTZ, ceftazidime; CUR, cefuroxime; GEN, gentamicin; MOX,
moxiﬂoxacin; TRS, trimethoprim-sulfamethoxazole; n.a., not assigned.
a as determined by VITEK® 2 automated system (bioMérieux) and MASTDISC™ ID ESβL-Set (CPD10) D67C (MAST Diagnostica). POS= positive.
b MICs were detected with VITEK® 2 (bioMérieux) and evaluated using breakpoints provided by EUCAST [15].
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(each in 2/11; 18.2%). None of these staphylococcal isolates were
methicillin-resistant.
4. Discussion
In recent decades, veterinary healthcare settings have been de-
scribed as places of origin for outbreaks caused by a variety of multi-
drug-resistant microorganisms (MDROs) [21–24]. Both MRSA and
ESBL-E are notorious resistance phenotypes in equine hospitals
[21,24–26]. Overall, 2.7–9.3% of horses carry MRSA upon admission to
veterinary hospitals [27,28]; 2.6% and 10.7% tested positive for nasal
and fecal colonization with ESBL-E, respectively [25]. Regarding MRS
other than S. aureus, a study that included 42 healthy horses from four
diﬀerent farms in Poland found that 28.6% were colonized in the nasal
cavities [29]. However, less data is available on the distribution of these
MDROs in the general equine population in Germany. Of note, the re-
gion in which the sampling was performed has a particularly high
density of animal production. As both MRSA and ESBL-E are wide-
spread among regional livestock, these farms may represent potential
sources for MDRO spread in non-hospitalized horses [30–32].
In the study group of 223 horses, we found nine horses colonized
with ESBL-E (4.0%), all identiﬁed as E. coli. This prevalence resembles
data from another study carried out in the UK, where 6.3% of 650 fecal
samples from non-hospitalized horses were positive for ESBL-E. coli
[33]. Studies on equine patients in veterinary clinical settings report on
even higher rates of 10.7% and 34.2% of ESBL-E carrying animals,
respectively [22,25] indicating the high potential of strain
dissemination and horizontal gene transfer among ESBL-encoding genes
under opportune environmental conditions. In the study group, ESBL-E.
coli carriage was shown to be signiﬁcantly associated with antibiotic
treatment. This ﬁnding is in line with data obtained from the human
population where antibiotic therapy has been identiﬁed as a risk factor
for the colonization and infection with ESBL-E in numerous studies
[34–36]. Even though strains recovered in this study were only present
as commensals in the respective horses, under favorable conditions, an
infection of the host or other animals and humans in contact, is a likely
scenario. The high potential of strain dissemination in veterinary clinics
was recently reported by Walther and colleagues who investigated the
suspected spread of an ESBL-E. coli clone across three equine patients
[24]. Furthermore, in an earlier study, the conjugal horizontal transfer
of blaCTX-M-1 genes between E. coli and Salmonella strains was shown in
vitro [51]. Accordingly, the horse stable environment needs to be more
acknowledged as a complex biocenosis consisting of a plethora of mi-
croorganisms (i.e. the microbiota) including pathogenic species and
their resistome, which comprise not only those of equine sources, but
also those from humans, which are in contact with the horses. This is of
particular importance in veterinary facilities where antibiotic treatment
generates selection pressure favoring the generation and distribution of
(multi-)resistant organisms, which may easily cross host-species bar-
riers.
Altogether, the prevalence of S. aureus-positive animals (6.7%) in
the group of 223 horses is comparable to data from Canada (7.9%) and
remains below the most recent data from healthy horses in Denmark
(13.5%) [37,38]. Of interest, half of the spa types identiﬁed in our study
Table 3
Resistance proﬁles of MRSA found in 223 horses.
Animal host Sampling site spa type Resistance genes Phenotypic antimicrobial susceptibility test proﬁle
CXIa-screening Other resistancesb
Mare Nasal t011 mecA POS BEN, CLI, ERY, GEN, OXA, TET, TRS
Mare Nasal t6867 mecA POS BEN, GEN, OXA, TET, TRS
BEN, benzylpenicillin; CLI, clindamycin; CXI, cefoxitin; ERY, erythromycin; GEN, gentamicin; OXA, oxacillin; TET, tetracycline; TRS, trimethoprim-sulfamethox-
azole.
a as determined by VITEK® 2 automated system (bioMérieux). POS=positive.















Mare (n = 6) Stallion (n = 3) Gelding (n = 11)
Fig. 1. Absolute numbers of mares, stallions and geldings of a subgroup (n=20) analyzed for colonization with any staphylococcal species.
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were also present in the Danish equine population [38]. This pattern is
also reﬂected in the colonization by methicillin-resistant strains. Even
though the number of MRSA-positive horses documented here (0.9%)
rather resembles numbers from studies investigating healthy horses in
other European countries (0.53–1.7%) than data obtained in Denmark
(4.2%), the major fraction of MRSA detected in Denmark was found to
belong to the typically livestock-associated clonal complex (CC) 398
[33,38–40]. This was also true for the two isolates (t011 and t6867,
both ST398) detected in our study. In 2017, the Danish population
accounted for about 5.7 million people and over 31 million pigs were
bred and slaughtered [41,42]. In 2016, about 88% of the Danish pig
farms tested positive for MRSA CC398 [43]. Accordingly, high pro-
portions of CC398 can be found in MRSA isolated from human infec-
tions in Denmark. In 2014, 16% of MRSA-related bloodstream infec-
tions and 21% of soft-tissue infections were caused by MRSA CC398
[44]. Correspondingly, in the rural regions around Münster, in 2018,
4210 farms with over four million pigs were registered [45] and at the
local university hospital, a relatively steady proportion of about 30% of
MRSA detected at hospital admission of the patients belonged to CC398
between 2010 and 2014. Of these, between 4% and 11% were obtained
from specimen associated with infections [46]. Moreover, in a recent
study on MDRO prevalence in companion animals also living in districts
around Münster, but without obvious contact to livestock, all MRSA
detected were also assigned to livestock-related clonal lineages [47].
Regarding staphylococcal species other than S. aureus, we found
nine diﬀerent species in the subgroup of 20 horses. All of them were
methicillin-susceptible, which is not surprising because mainly healthy
horses outside of healthcare facilities were enrolled. Among these, the
coagulase-positive species and SIG member Staphylococcus delphini was
detected in one horse. Resistant strains of this species have been de-
scribed in equine samples before [48]. Apart from S. aureus, other
staphylococci are often neglected when screenings for methicillin-re-
sistant strains are performed. This can be problematic, as, for example,
carriage of MRS in horses has been shown to occur at a high frequency
and strains are also capable of causing disease and transferring methi-
cillin resistance genes towards more pathogenic species, such as S.
aureus [33,49,50]. Accordingly, even though in this study group no
MRS besides MRSA was found, particular attention needs to be paid to
these strains in future analysis.
5. Conclusion
In this study, a considerable number of multiresistant pathogenic
species, in particular ESBL-E. coli, was detected in a group of non-
hospitalized, mainly healthy horses living in rural districts surrounded
by livestock production farms. Although only infrequently found, the
exclusive presence of MRSA isolates belonging to the livestock-asso-
ciated CC398 lineage underlines the impact of livestock farming on the
geographic distribution of epidemic strains. Transmission of MDROs to
humans which are in close contact to MDRO-colonized horses and their
environment may be an underestimated risk. A consequent realization
of the “One Health” concept is crucial for the containment of antibiotic
resistances.
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